HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing

Journal of Leukocyte Biology

Volumn 78, Issue 1, 2005, Pages 95-105

  Bellemare Pelletier, Angélique ^a   Tremblay, Jessy ^a   Beaulieu, Sylvie ^b   Boulassel, Mohamed Rachid ^c   Routy, Jean Pierre ^c   Massie, Bernard ^d   Lapointe, Réjean ^e   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e NOTRE DAME HOSPITAL   (Canada)

Author keywords

CLIP; HLA DM; HLA DR; Invariant chain; MHC

Indexed keywords

ADENOVIRUS VECTOR; CHAPERONE; CLIP PROTEIN; GLYCOPROTEIN GP 100; HLA DM ANTIGEN; HLA DO ALPHA ANTIGEN; HLA DO ANTIGEN; HLA DO BETA ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE FRAGMENT; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL MEMBRANE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE VESICLE; MIXED LYMPHOCYTE REACTION; MODULATION; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 22144474382     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0105020     Document Type: Article

References (82)

1. Germain, R. N. (1994) MHC-dependant antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
2. Pieters, J. (1997) MHC class II-restricted antigen presentation. Curr. Opin. Immunol. 9, 89-96.
3. Cresswell, P. (1994) Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-203.
4. Cresswell, P. (1996) Invariant chain structure and MHC class II function. Cell 84, 505-507.
5. Sanderson, F., Kleijmeer, M. J., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J. J., Geuze, H. J., Trowsdale, J. (1994) Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-1569.
6. Pierre, P., Denzin, L. K., Hammond, C., Drake, J. R., Amigorena, S., Cresswell, P., Mellman, I. (1996) HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 4, 229-239.
7. Denzin, L. K., Cresswell, P. (1995) HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
8. Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., Zaller, D. M. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
9. Alfonso, C., Karlsson, L. (2000) Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18, 113-142.
10. Chen, X., Jensen, P. E. (2004) The expression of HLA-DO (H2-O) in B lymphocytes. Immunol. Res. 29, 19-28.
11. Liljedahl, M., Kuwana, T., Fung-Leung, W. P., Jackson, M., Peterson, P. A., Karlsson, L. (1996) HLA-DO is a lysosomal resident, which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15, 4817-4824.
12. Douek, D. C., Altmmann, D. M. (1997) HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9, 355-364.
13. Brunet, A., Samaan, A., Deshaies, F., Kindt, T. J., Thibodeau, J. (2000) Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DOβ. J. Biol. Chem. 275, 37062-37071.
14. van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H., Reits, E., Pastoors, L., Neefjes, J. (2001) Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 167, 884-892.
15. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J., Cresswell, P. (1997) Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science, 278, 106-109.
16. Van Ham, S. M., Tjin, F. P. M., Lillemeier, B. F., Gruneberg, U., Van Meijgaarden, K. E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., Ottenhoff, T. H., Pappin, D. J., Towsdale, J., Neefjes, J. (1997) HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7, 950-957.
17. van Ham, M., van Litli, M., Lillemeier, B., Tjin, E., Gruneberg, U., Rahman, D., Pastoors, L., van Meijgaarden, K., Roucard, C., Trowsdale, J., Ottenhoff, T., Pappin, D., Neefjes, J. (2000) Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 191, 1127-1136.
18. Liljedahl, M., Winqvist, O., Surh, C. D., Wong, P., Ngo, K., Teyton, L., Peterson, P. A., Brunmark, A., Rudensky, A. Y., Fung-Leung, W. P., Karlsson, L. (1998) Altered antigen presentation in mice lacking H2-O. Immunity 8, 233-243.
19. Kropshofer, H., Vogt, A. B., Thery, C., Armandola, E. A., Li, B. C., Moldenhauer, G., Amigorena, S., Hammerling, G. J. (1998) A rule for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 17, 2971-2981.
20. Brocke, P., Armandola, E., Garbi, N., Hammerling, G. J. (2003) Down-modulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes. Eur. J. Immunol. 33, 411-421.
21. Alfonso, C., Williams, G. S., Han, J. O., Westberg, J. A., Winqvist, O., Karlsson, L. (2003) Analysis of H2-O influence on antigen presentation by B cells. J. Immunol. 171, 2331-2337.
22. Perraudeau, M., Taylor, P. R., Stauss, H. J., Lindstedt, R., Bygrave, A. E., Pappin, D. J., Ellmerich, S., Whitten, A., Rahman, D., Canas, B., Walport, M. J., Botto, M., Altmann, D. M. (2000) Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur. J. Immunol. 30, 2871-2880.
23. Rohn, T. A., Boes, M., Wolters, D., Spindeldreher, S., Muller, B., Langen, H., Ploegh, H., Vogt, A. B., Kropshofer, H. (2004) Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type I polarization. Nat. Immunol. 5, 909-918.
24. Tonnelle, C., DeMars, R., Long, E. O. (1985) DOβ: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J. 4, 2839-2847.
25. Karlsson, L., Surh, C. D., Sprent, J., Peterson, P. A. (1991) A novel class II MHC molecule with unusual tissue distribution. Nature 351, 485-488.
26. Trowsdale, J., Kelly, A. (1985) The human HLA class II α chain DZα is distinct from genes in the DP, DQ and DR subregions. EMBO J. 4, 2231-2237.
27. Taxman, D. J., Cressman, D. E., Ting, J. P. (2000) Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN α/DO β heterodimer. J. Immunol. 165, 1410-1416.
28. Chen, X., Liur, O., Kambayashi, T., Li, S., Bray, R. A., Weber, D. A., Karlssoll, L., Jensen, P. E. (2002) Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 195, 1053-1062.
29. Fallas, J. L., Tobin, H. M., Lou, O., Guo, D., Sant'Angelo, D. B., Denzin, L. K. (2004) Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J. Immunol. 173, 1549-1560.
30. Mellman, I., Steimnan, R. M. (2001) Dendritic cells: specialized and regulated antigen-processing machines. Cell 106, 255-258.
31. Bryant, P., Ploegh, H. (2004) Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16, 96-102.
32. Siemasko, K., Eisfelder, B. J., Williamson, E., Kabak, S., Clark, M. R. (1998) Signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J. Immunol. 160, 5203-5208.
33. Lankar, D., Vincent-Schneider, H., Briken, V., Yokozeki, T., Raposo, G., Bonnerot, C. (2002) Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation. J. Exp. Med. 195, 461-472.
34. Santambrogio, L., Sato, A. K., Carven, G. J., Belyanskaya, S. L., Strominger, J. L., Stern, L. J. (1999) Extracellular antigen processing and presentation by immature dendritic cells. Proc. Natl. Acad. Sci. USA 96, 15056-15061.
35. Thery, C., Amigorena, S. (2001) The cell biology of antigen presentation in dendritic cells. Curr. Opin. Immunol. 13, 45-51.
36. Cella, M., Engering, A., Pinet, V., Pieters, J., Lanzavecchia, A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787.
37. Pierre, P., Turley, S. J., Gatti, E., Hull, M., Meltzer, J., Mirza, A., Inaba, K., Steinman, R. M., Mellman, I.(1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792.
38. Alfonso, C., Williams, C. S., Karlsson, L. (2003) H2-O influence on antigen presentation in H2-E-expressing mice. Eur. J. Immunol. 33, 2014-2021.
39. Lampson, L. A., Levy, R. (1980) Two populations of 1a-like molecules on a human B cell line. J. Immunol. 125, 293-299.
40. Panina-Bordignon, P., Fu, X., Lanzavecohia, A., Karr, R. W. (1992) Identification of HLA-DR α chain residues critical for binding of the toxic shock syndrome toxin superantigen. J. Exp. Med. 176, 1779-1784.
41. Khalil, H., Deshaies, F., Bellemare-Pelletier, A., Brunet, A., Faubert, A., Azar, G. A., Thibodean, J. (2002) Class II transactivator-induced expression of HLA-DO(β) in HeLa cells. Tissue Antigens 60, 372-382.
42. Denzin, L. K., Robbins, N. F., Carboy-Newcomb, C., Cresswell, P. (1994) Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1, 595-606.
43. Glazier, K. S., Hake, S. B., Tobin, H. M., Chadburn, A., Schattner, E. J., Denzin, L. K. (2002) Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J. Exp. Med. 195, 1063-1069.
44. Lamarche, N., Massie, B., Richer, M., Paradis, H., Langelier, Y. (1990) High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J. Gen. Virol. 71, 1785-1792.
45. Ogorelkova, M., Elahi, S. M., Gagnon, D., Massie, B. (2004) DNA delivery to cells in culture: generation of adenoviral libraries for high-throughput functional screening. Methods Mol. Biol. 246, 15-27.
46. He, T. C., Zhon, S., da Costa, L. T., Yu, J., Kinzler, K. W., Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514.
47. Lapointe, R., Bellemare-Pelletier, A., Houssean, F., Thibodeau, J., Hwu, P. (2003) CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res. 63, 2836-2843.
48. Lapointe, R., Royal, R. E., Reeves, M. K., Altomare, I., Robbins, P. F., Hwu, P. (2001) Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100. J. Immunol. 167, 4758-4764.
49. Sallusto, F., Lanzaveechia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
50. Engleman, E. G. (2003) Dendritic cell-based cancer immunotherapy. Semin. Oncol. 30, 23-29.
51. Mommaas, A. M., Mulder, A. A., Jordens, R., Out, C., Tan, M. C., Cresswell, P., Kluin, P. M., Koning, F. (1999) Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of ULA class II molecules. Eur. J. Immunol. 29, 571-580.
52. Crystal, R. G. (1999) In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors. Cancer Chemother. Pharmacol. 43, S90-S99.
53. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell R. L., Finberg, R. W. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
54. Wickham, T. J., Mathias, P., Cheresh, D. A., Nemerow, G. R. (1993) Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
55. Qi, L., Ostrand-Rosenberg, S. (2001) H2-O inhibits presentation of bacterial superantigens, but not endogenous self-antigens. J. Immunol. 167, 1371-1378.
56. Miyazaki, T., Wolf, P., Tourne, S., Waltzinger, C., Dierich, A., Barois, N., Ploegh, H., Benoist, C., Mathis, D. (1996) Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84, 531-541.
57. Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., Levitsky, H. (1998) The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 188, 2357-2368.
58. Pardoll, D. M., Topalian, S. L. (1998) The role of CD4+ T cell responses in antitumor immunity. Curr. Opin. Immunol. 10, 588-594.
59. Topalian, S. (1994) MHC class II-restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy. Curr. Opin. Immunol,. 6, 741-745.
60. Sanderson, S., Frauwirth, K., Shastri, N. (1995) Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc. Natl. Acad. Sci. USA 92, 7217-7221.
61. Van Bergen, J., Schoenberger, S. P., Verreck, F., Amons, R., Offringa, R., Koning, F. (1997) Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP. Proc. Natl. Acad. Sci. USA 94, 7499-7502.
62. Ostrand-Rosenberg, S., Pulaski, B. A., Clements, V. K., Qi, L., Pipeling, M. R., Hanyok, L. A. (1999) Cell-based vaccines for the stimulation of immunity to metastatic cancers. Immunol. Rev. 170, 101-114.
63. Qiu, G., Goodchild, J., Humphreys, R. E., Xu, M. (1999) Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells. Cancer Immunol. Immunother. 48, 499-506.
64. Lightstone, L., Hargreaves, R., Bobek, G., Peterson, M., Aichinger, G., Lombardi, G., Lechler, R. (1997) In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides, which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA 94, 5772-5777.
65. Nanda, N. K., Sant, A. J. (2000) DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192, 781-788.
66. Blum, J. S., Ma, C., Kovats, S. (1997) Antigen-presenting cells and the selection of immunodominant epitopes. Crit. Rev. Immunol. 17, 411-417.
67. Lally, K. M., Mocellin, S., Ohnmacht, G. A., Nielsen, M. B., Bettinotli, M., Panelli, M. C., Monsurro, V., Marincola, F. M. (2001) Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading. Int. J. Cancer 93, 841-847.
68. Bezwoda, W. R., Seymour, L., Dansey, H. D. (1995) High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J. Clin. Oncol. 13, 2483-2489.
69. Jones, R. J., Ambinder, R. F., Piantadosi, S., Santos, G. W. (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77, 649-653.
70. Takvorian, T., Canellos, G. P., Ritz, J., Freedman, A. S., Anderson, K. C., Mauch, P., Tarbell, N., Coral, F., Daley, H., Yeap, B. (1987) Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N. Engl. J. Med. 316, 1499-1505.
71. Hess, A. D., Thoburn, C. J. (1997) Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol. Rev. 157, 111-123.
72. Hess, A. D., Bright, E. C., Thoburn, C., Vogelsang, G. B., Jones, R. J., Kennedy, M. J. (1997) Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of major histocompatibility complex class II invariant chain peptide. Blood 89, 2203-2209.
73. Taxman, D. J., Cressman, D. E., Ting, J. P. (2000) Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN α/DO β heterodimer. J. Immunol. 165, 1410-1416.
74. Landmann, S., Muhlethaler-Mottet, A., Bernasconi, L., Suter, T., Waldburger, J. M., Masternak, K., Arrighi, J. F., Hauser, C., Fontana, A., Reith, W. (2001) Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J. Exp. Med. 194, 379-391.
75. Schumacher, L., Ribas, A., Dissette, V. B., McBride, W. H., Mukherji, B., Economou, J. S., Butterfield, L. H. (2004) Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J. Immunother. 27, 191-200.
76. Rea, D., Schagen, F. H., Hoehen, R. C., Mehtali, M., Havenga, M. J., Toes, R. E., Melief, C. J., Offringa, R. (1999) Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73, 10245-10253.
77. Marten, A., Ziske, C., Schottker, B., Weineck, S., Renoth, S., Buttgereit, P., Schakowski, F., Konig, S., von Rucker, A., Allera, A., Schroers, R., Sauerbrueh, T., Wittig, B., Schmidt-Wolf, I. G. (2001) Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs. Cancer Gene Ther. 8, 211-219.
78. Hillman, G. G., Kallinteris, N. L., Li, J., Wang, Y., Lu, X., Li, Y., Wu, S., Wright, J. L., Slos, P., Gulfo, J. V., Humphreys, R. E., Xu, M. (2003) Generating MHC class II +/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC class II inducer and an antisense Ii-RNA construct in tumor cells. Gene Ther. 10, 1512-1518.
79. Mellman, I., Turley, S. J., Steinman, R. M. (1998) Antigen processing for amateurs and professionals. Trends Cell Biol. 8, 231-237.
80. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., Amigorena, S. (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667.
81. Perrin-Cocon, L. A., Villiers, C. L., Salamero, J., Gabert, F., Marche, P. N. (2004) B cell receptors and complement receptors target the antigen to distinct intracellular compartments. J. Immunol. 172, 3564-3572.
82. Chaturvedi, P., Hengeveld, R., Zechel, M. A., Lee-Chan, E., Singh, B. (2000) The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses. Int. Immunol. 12, 757-765.